Ocella™ and Cardiovascular Risks
Ocella™ is an oral birth control medication that was approved by the U.S. Food and Drug Administration (FDA) in 2008. Like Beyaz®, Yaz®, and Yasmin®, the drug contains drospirenone—a synthetic progestin hormone. Drospirenone has been linked to an increased risk of cardiovascular issues in some patients.
If you or someone you care about took Ocella and suffered severe cardiovascular side effects, Ferrer, Poirot & Wansbrough wants to help. Our Ocella recall lawyers can help you get the compensation you deserve for your medical bills, lost wages, and pain and suffering. Contact our legal staff 24 hours a day, seven days a week—call (800) 210-8503 or complete a free initial consultation form, today.
What Are Ocella™ Risks?
Ocella can increase potassium levels in a patient’s bloodstream. High potassium levels may lead to a condition called hyperkalemia, which can cause potentially serious heart and health problems—including fatal heart arrhythmias. As a result, women taking Ocella may be at risk for drug interactions that could increase potassium, and any other possible drug interactions common to oral contraceptives.
In addition to the risks posed by increased potassium levels, Ocella also increases the risk of blood clots. In September 2011, the FDA reported that women taking birth control products containing drospirenone have a 1.5 times greater risk of blood clots compared to women who take other hormonal contraceptives.
Other serious side effects linked to Ocella include:
- deep vein thrombosis,
- heart attack,
- pulmonary embolism,
- and stroke.
We’re Here to Help
You shouldn’t have to pay for a drug company’s negligence. At Ferrer, Poirot & Wansbrough, our Ocella recall lawyers give a voice to the victims of prescription drugs. Let us protect your rights to the compensation you deserve—contact us today.
Ocella™ is a trademark of Barr Laboratories, Inc. and is only used here only to identify the product in question.
Yasmin®, Yaz®, and Beyaz® are registered trademarks of Bayer HealthCare Pharmaceuticals and are used here only to identify the product in question.
This law firm is not associated with, sponsored by, or affiliated with Barr Laboratories, Inc., Bayer HealthCare Pharmaceuticals or the U.S. Food and Drug Administration.